Actively Recruiting
Advances in Neuropsychological Diagnostics for Cognitive and Psychiatric Disorders
Led by Istituto Auxologico Italiano ยท Updated on 2025-09-17
300
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to improve neuropsychological diagnostics by developing, calibrating, and evaluating new clinical and forensic neuropsychological tests. These tests focus on both instrumental and non-instrumental functions and are being studied in neurologically healthy individuals representing the Italian population, as well as in patients with various neurological and neuropsychiatric conditions. The goal is to modernize and expand diagnostic tools to meet clinical and forensic needs, including remote testing and assessments of testamentary capacity. Participants include people with brain disorders and neurologically healthy controls. The study involves cognitive and behavioral tests and questionnaires designed to assess various mental functions. These tests will be administered at baseline, then repeated after one month for healthy participants, and at 6, 12, and 18 months for those with neurodegenerative disorders to evaluate changes over time. Throughout the study, participants will undergo multiple assessments including tests like the Brief Assessment of Social Skills-Dementia, Picture Interpretation Test, and Telephone Interview for Cognitive Status among others. These evaluations are done at enrollment and at scheduled intervals to monitor cognitive and behavioral changes. The study will track outcomes to understand test reliability and clinical usefulness over an extended period, with participation lasting up to 18 months for some individuals.
CONDITIONS
Brief Title
Advances in Neuropsychological Diagnostics
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 20 to 100 years
- Clinical diagnosis of neurological or psychiatric disorders for clinical populations
- Neurologically healthy individuals for healthy controls
You will not qualify if you...
- Clinical diagnosis not of interest for clinical populations
- Severe general medical conditions
- Uncorrected vision or hearing deficits
- Presence of brain disorders for healthy controls
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Baseline, 1 month, and up to 18 months
Participants complete neuropsychological instruments including cognitive and behavioral tests and questionnaires at enrollment and subsequent time points.
Multiple visits at baseline, 1 month, 6 months, 12 months, and 18 months
Duration - Up to 18 months
Participants with neurodegenerative disorders are monitored over time to assess changes in cognitive and psychiatric function.
Follow-up visits at 6, 12, and 18 months
Trial Site Locations
Total: 1 location
1
Istituto Auxologico Italiano IRCCS
Milan, Lombardy, Italy, 20122
Actively Recruiting
Research Team
N
Nadia Bolognini, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here